San Francisco, 4 April 2019: The Report Radiofrequency Ablation Devices Market Size, Share & Trends Analysis Report By Product
(Disposable, Capital, Reusable Equipment), By Application, By Region, And
Segment Forecasts, 2019 - 2026
The global radiofrequency ablation devices market size is anticipated to reach USD 6.7 billion by 2026,
according to a new report by Grand View Research, Inc. It is expected to
register a CAGR of 11.6% during the forecast period. Increasing preference for
minimally invasive surgeries, growing geriatric population, and rise in
healthcare spending for better disease treatment are expected to propel the
growth.
According to the American Society of
Plastic Surgeons, by the end of 2015, 15.9 million minimally invasive cosmetic
surgeries were performed in U.S. According to the Centers for Disease Control
and Prevention (CDC), more than six million laparoscopic procedures are
performed across the U.S. and EU countries every year.
Radiofrequency ablation is now used early
in the management of patients suffering from atrial tachycardia or atrial
fibrillation or other kinds of coronary disease. This factor is anticipated to
boost the market growth. According to the American College of Cardiology
Foundation, coronary heart disease is the leading cause of deaths (43.8%) in
U.S., followed by stroke (16.8%), heart failure (9.0%), high BP (9.4%), and
other CVDs (17.9%). By 2035, the total cost of CVD is expected to reach USD 1.1
trillion and is projected to affect 45.1% (130 million) adults in U.S.
Radiofrequency ablation can also be used to
reduce neck pain, low-back pain, arthritis, and pelvic and peripheral nerve
pain. According to WebMD LLC., RFA has been proven to be effective in more than
70% of the patients experiencing pain. Pain relief from RFA can last from six to
12 months or even a year.
Access Research Report of Radiofrequency
Ablation Devices Market @ https://www.grandviewresearch.com/industry-analysis/radiofrequency-ablation-devices-market
Further key findings from the report suggest:
· Disposable equipment held the largest
market share in 2018 due to reduced morbidity and mortality and the ability of
the equipment to provide treatment in an outpatient setting. For example,
Radiopaque RF cannula (Halyard Worldwide, Inc) provides improved visualization
under fluoroscopy for accurate positioning, resulting in a targeted treatment
· Cardiology and cardiac rhythm management is
anticipated to be the fastest-growing segment during the forecast period due to
disease prevalence, growing awareness, and adoption of minimally invasive
operations. In 2012 RFA-Academia launched an initiative to increase awareness
in Europe and to teach endoscopists safe and justified application of RFA to
reduce the disease burden
· North America is anticipated to continue
leading the radiofrequency ablation devices market during the forecast period
due to high healthcare expenditure, incidence of cardiac disease and cancer,
and the number of patients suffering from pain
· Asia Pacific is expected to witness
significant growth over the next decade due to increasing demand for minimally
invasive procedures to treat cancer and growing awareness regarding the benefits
of ablation method over the conventional surgical procedures
· Some of the key players are Boston
Scientific Corporation; Medtronic; Stryker; Cosman Medical, Inc.; St. Jude
Medical; Smith & Nephew; Johnson & Johnson (J&J) Services, LLC; and
AngioDynamics.
Browse more reports of this category by Grand View
Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has
segmented the global radiofrequency ablation devices market based on type and
region:
Radiofrequency Ablation Devices Product
Outlook (Revenue, USD Million, 2015 - 2026)
·
Disposable Equipment
·
Capital Equipment
·
Reusable Equipment
Radiofrequency Ablation Devices Mode of
Delivery Outlook (Revenue, USD Million, 2015 - 2026)
·
Surgical Oncology
·
Cardiology & Cardiac Rhythm Management
·
Cosmetology
·
Gynecology
·
Pain Management
Radiofrequency Ablation Devices Regional
Outlook (Revenue, USD Million, 2015 - 2026)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Access Press Release of
Radiofrequency Ablation Devices Market@ https://www.grandviewresearch.com/press-release/global-radiofrequency-ablation-devices-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment